MSD patient safety campaign tackles counterfeits
November 10, 2005Sales and Marketing
Merck Sharp & Dohme has launched a public information campaign warning of the the dangers of buying 'lifestyle' drugs over …
New advertising checks could delay UK launches
November 10, 2005Sales and Marketing
The MHRA has conceded that checks on advertising and promotional materials for new prescription medicines could delay their UK launch …
Enhancing the drug development process
November 9, 2005Research and Development
MEDICAL SOLUTIONS SPONSORED FEATURERecently, we have seen a massive increase in our knowledge and understanding of the biochemical mechanisms that, …
Bextra suspension confirmed in EU
November 9, 2005Sales and Marketing
The European Commission has confirmed that Pfizer's Cox-II product Bextra will remain suspended from the market because of safety concerns.The …
Ebixa takes on Alzheimer’s market leaders
November 9, 2005Sales and Marketing
Lundbeck's Alzheimer's treatment Ebixa will compete directly with the leading treatments for the moderate form of the disease following an …
New Aptivus launched in Europe for resistant HIV
November 9, 2005Sales and Marketing
Boehringer Ingelheim's new treatment for patients with drug-resistant HIV has been approved by the EMEA.The prevalence of drug-resistant HIV is …
UK approval for severe asthma treatment Xolair
November 9, 2005Sales and Marketing
Novartis has received UK approval for Xolair, its novel monoclonal antibody treatment for severe persistent allergic asthma.The first drug in …
Tarceva receives approval for pancreatic cancer in the US
November 8, 2005Sales and Marketing
Roche and Genentech's Tarceva has been approved in the US for the treatment of pancreatic cancer – one of the …
Pharma’s changing salesforces
November 8, 2005Sales and Marketing
The traditional salesforce model has served the industry well for 30-40 years and has been one of the biggest drivers …
US acquisitions a coup for Cambridge Antibody
November 8, 2005Research and Development
Cambridge Antibody Technology has bought two promising oncology candidates from US biotech company Genencor, and has established its first research …
Industry’s European price ‘free riding’ claim refuted
November 8, 2005Sales and Marketing
Long-standing claims that the US has been burdened with high medicines prices because of 'free riding' by European countries have …
NHS clinical leaders oppose mergers
November 8, 2005More than three quarters of lead clinicians believe proposed mergers of Primary Care Trusts will harm patient care, according to …
R&D Scoreboard poor gauge of pharma investment in the UK
November 8, 2005Research and Development AstraZeneca, GSK, Pfizer, R&D, R&D scoreboard
The R&D Scoreboard is fundamentally flawed as a measure of R&D investment in the UK and pharmaceutical companies are continuing …
Marketers and levels of leadership
November 7, 2005Sales and Marketing
Trends come and go in the pharma industry – just like in any other – but one which has stuck …
Prescribing powers proposed for new NHS support workers
November 4, 2005Around 3,000 new healthcare support workers will provide clinical care across primary and secondary care, according to the government's latest …
NICE unveils fast track process
November 3, 2005Sales and Marketing
Cancer drugs will be the first treatments to benefit from changes designed to speed up the way NICE makes its …
200,000 quitters to boost NRT sales
November 3, 2005Sales and Marketing
Manufacturers of nicotine replacement therapy products can expect sales to rise when England's partial smoking ban is introduced.The government anticipates …
Radical change for NHS in Scotland
November 3, 2005Healthcare services across Scotland are to focus on preventative care as part of wide-ranging changes to NHS priorities in the …
Government retreat on handing over PCT services
November 3, 2005The government has retreated on plans for a mandatory opening up of primary care services to alternative providers.Health secretary Patricia …
Don’t blush…look before you flush’
November 3, 2005Medical Communications
Bowel Cancer UK has been launched with a new campaign to promote personal awareness of the disease that kills 16,000 …
Latest content
FibroFind appoints Lee Borthwick as CEO
